Lacosamide Strides (Lacosamide)

• Lacosamide is an antiepileptic drug that modulates neuronal sodium channels to control seizure activity.
• Partial‑onset seizures: reduces the frequency of focal seizures in patients with epilepsy.
• Adjunctive therapy for focal epilepsy: provides additional seizure control when other agents are insufficient.
• Monotherapy for partial‑onset seizures: can be used alone to manage focal seizure disorders.

• Lacosamide enhances the slow inactivation of voltage‑gated sodium channels, stabilizing neuronal membranes and decreasing hyper‑excitability. By selectively targeting the persistent sodium current, it limits repetitive neuronal firing without affecting normal channel function, thereby reducing the propagation of epileptic discharges.

Lacosamide may cause a range of adverse reactions, from mild to serious.

Common Side Effects

• Dizziness
• Headache
• Nausea
• Fatigue
• Blurred vision
• Diplopia

Serious or Rare Side Effects

• Suicidal thoughts or behavior
• Severe skin reactions such as Stevens‑Johnson syndrome
• Cardiac conduction abnormalities (e.g., PR‑interval prolongation)
• Respiratory depression
• Anaphylactic reactions

When prescribing Lacosamide, clinicians should consider several safety factors.

• Renal impairment: monitor renal function and adjust dosing as needed.
• Hepatic impairment: use with caution and observe liver enzymes.
• Cardiac conduction disorders: obtain baseline ECG and monitor for PR‑interval changes.
• Concomitant CNS depressants: assess for enhanced sedation.
• Pregnancy: risk category unknown; discuss potential benefits and risks with the prescriber.
• Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Lacosamide can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid)

• Carbamazepine: may lower lacosamide plasma concentrations.
• Phenytoin: can diminish lacosamide effectiveness.
• Strong CYP3A4 inducers (e.g., rifampicin): may decrease exposure.

Moderate Interactions (Monitor Closely)

• CNS depressants (e.g., benzodiazepines): may increase dizziness or sedation.
• Alcohol: can enhance central nervous system effects.
• Other antiepileptics (e.g., valproate): monitor seizure control and plasma levels.